Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-21

Clinical Trial Update: Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the efficacy and safety of Ikervis under controlled environmental conditions for dry eye conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ikervis (ciclosporin ophthalmic emulsion)

Snippet

Sponsor: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | Conditions: Dry Eye, Dry Eye Syndromes | Phase 4 | Status: COMPLETED